These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20430537)

  • 21. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
    Judson G; Bird R; O'Connor P; Bevin T; Loan R; Schroder M; McGrath R; Weatherall M; Moriarty H; Robinson G
    Drug Alcohol Rev; 2010 Jan; 29(1):41-6. PubMed ID: 20078681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
    Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
    Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
    Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone maintenance therapy outcomes in Iran.
    Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
    Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HCV prevalence in methadone maintenance: self-report versus serum test.
    Weaver MF; Cropsey KL; Fox SA
    Am J Health Behav; 2005; 29(5):387-94. PubMed ID: 16201855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China--a prospective study.
    Chen W; Xia Y; Hong Y; Hall BJ; Ling L
    Harm Reduct J; 2013 Oct; 10():23. PubMed ID: 24107380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of methadone treatment on incarceration rates among injection drug users.
    Werb D; Kerr T; Marsh D; Li K; Montaner J; Wood E
    Eur Addict Res; 2008; 14(3):143-9. PubMed ID: 18552490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
    Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
    J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors for hepatitis C among injecting drug users in Oslo].
    Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
    N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing.
    Li D; Chu P; Yang Y; Li S; Ruan Y; Liu Z; Cao X; Lu L; Jia Z
    J Addict Med; 2012 Dec; 6(4):311-7. PubMed ID: 23041679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics.
    Tran BX; Ohinmaa A; Duong AT; Nguyen LT; Vu PX; Mills S; Houston S; Jacobs P
    Drug Alcohol Depend; 2012 Oct; 125(3):260-6. PubMed ID: 22436971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach.
    Bleich A; Gelkopf M; Weizman T; Adelson M
    Isr J Psychiatry Relat Sci; 2002; 39(2):104-12. PubMed ID: 12227225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating hepatitis C virus infection in active substance users.
    Sylvestre DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users.
    Robinson GM; Reynolds JN; Robinson BJ
    N Z Med J; 1995 Mar; 108(996):103-5. PubMed ID: 7715873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.